Madrigal Pharmaceuticals, Inc.
MDGL· Nasdaq
Released Jul 20, 2016, after the close
10-Q filed Jul 20, 2016, 20 days after period end · 0001104659-16-133512
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q2 2016 | Q2 2015 | Q2 2014 | Q2 2013 |
|---|---|---|---|---|
| EPS Diluted | -$16.33 | -$0.15 | -$0.24 | -$0.33 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Madrigal Pharmaceuticals, Inc. · CIK 1157601 · Engraved from SEC EDGAR
ended Jun 30, 2016 · filed Jul 20, 2016 · 20 d after period end